DuChemBIO Co.,Ltd. (KOSDAQ:176750)
South Korea
· Delayed Price · Currency is KRW 9,010.00
-50.00 (-0.55%)
At close: Apr 28, 2026
DuChemBIO Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
| Operating Revenue | 38,572 | 35,601 | 34,695 |
| Other Revenue | -0 | - | -0 |
| Revenue | 38,572 | 35,601 | 34,695 |
| Revenue Growth (YoY) | 8.35% | 2.61% | - |
| Cost of Revenue | 24,342 | 23,367 | 22,898 |
| Gross Profit | 14,230 | 12,234 | 11,797 |
| Selling, General & Admin | 5,430 | 5,548 | 5,087 |
| Research & Development | 22.57 | - | 205.31 |
| Amortization of Goodwill & Intangibles | 982.07 | 977.8 | 979.73 |
| Operating Expenses | 6,787 | 7,158 | 6,541 |
| Operating Income | 7,443 | 5,076 | 5,256 |
| Interest Expense | -1,062 | -1,091 | -1,364 |
| Interest & Investment Income | 221.64 | 89.64 | 90.89 |
| Earnings From Equity Investments | -24.69 | 1,106 | -69.64 |
| Currency Exchange Gain (Loss) | -4.77 | -34.84 | -7.99 |
| Other Non Operating Income (Expenses) | -54.72 | 30.23 | 68.38 |
| EBT Excluding Unusual Items | 6,519 | 5,177 | 3,974 |
| Gain (Loss) on Sale of Investments | 207.24 | 387.82 | 92.13 |
| Gain (Loss) on Sale of Assets | 2.85 | -0.18 | 16.28 |
| Asset Writedown | -72.81 | - | -30.7 |
| Pretax Income | 6,656 | 5,564 | 4,052 |
| Income Tax Expense | 176.72 | -2,429 | 51.23 |
| Net Income | 6,480 | 7,994 | 4,001 |
| Net Income to Common | 6,480 | 7,994 | 4,001 |
| Net Income Growth | -18.94% | 99.82% | - |
| Shares Outstanding (Basic) | 28 | 27 | 27 |
| Shares Outstanding (Diluted) | 28 | 27 | 27 |
| Shares Change (YoY) | 5.75% | 0.43% | - |
| EPS (Basic) | 228.61 | 297.54 | 149.54 |
| EPS (Diluted) | 228.00 | 297.54 | 149.54 |
| EPS Growth | -23.37% | 98.97% | - |
| Free Cash Flow | 9,074 | 5,440 | 7,293 |
| Free Cash Flow Per Share | 319.36 | 202.48 | 272.63 |
| Gross Margin | 36.89% | 34.36% | 34.00% |
| Operating Margin | 19.30% | 14.26% | 15.15% |
| Profit Margin | 16.80% | 22.45% | 11.53% |
| Free Cash Flow Margin | 23.52% | 15.28% | 21.02% |
| EBITDA | 14,313 | 10,641 | 11,016 |
| EBITDA Margin | 37.11% | 29.89% | 31.75% |
| D&A For EBITDA | 6,870 | 5,565 | 5,760 |
| EBIT | 7,443 | 5,076 | 5,256 |
| EBIT Margin | 19.30% | 14.26% | 15.15% |
| Effective Tax Rate | 2.66% | - | 1.26% |
| Advertising Expenses | 172.04 | 76.18 | 62.35 |
Source: S&P Capital IQ. Standard template. Financial Sources.